Statement 28 September 2022

IFPMA statement at the 74th session of the WHO Regional Committee for the Americas on the COVID-19 pandemic in the region of the Americas


28 September 2022, Washington, DC, USA — IFPMA welcomes the opportunity to share our from Covid-19 Lessons Learned, which highlights that swift pathogen surveillance and sharing, an enabling innovation ecosystem, and regulatory agility must be preserved to ensure our collective ability to fight against unknown diseases. The most important lesson of the report is that we must redouble collective efforts to achieve health equity, while ensuring health systems and delivery infrastructure are strengthened. These learnings have resulted in industry tabling the Berlin Declaration, which proposes to create a collaborative solution for more equitable rollout of vaccines, treatments, and diagnostics for future pandemics. In concrete terms, industry commits to setting aside doses specifically for poorer countries at the outset of a future pandemic. A prerequisite for the declaration to succeed is to ensure that health systems in lower-income countries are better prepared to absorb and deliver vaccines and treatments, and for high income countries to provide the necessary political and financial support.

As discussions continue on how to strengthen health emergency preparedness, we must bear in mind that any future global health architecture must acknowledge a multistakeholder structure, including industry, public agencies, multilateral organizations, financial institutions, governments, and philanthropic organizations. This is the only viable solution to managing pandemic crises in the region and beyond.


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster